Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q13421
UPID:
MSLN_HUMAN
Alternative names:
CAK1 antigen; Pre-pro-megakaryocyte-potentiating factor
Alternative UPACC:
Q13421; D3DU65; Q14859; Q4VQD5; Q96GR6; Q96KJ5; Q9BR17; Q9BTR2; Q9UCB2; Q9UK57
Background:
Mesothelin, identified by its alternative names such as CAK1 antigen and Pre-pro-megakaryocyte-potentiating factor, plays a crucial role in cellular processes. Its functions include facilitating cellular adhesion through its membrane-anchored forms and enhancing megakaryocyte colony formation in vitro as a Megakaryocyte-potentiating factor (MPF).
Therapeutic significance:
Understanding the role of Mesothelin could open doors to potential therapeutic strategies. Its involvement in cellular adhesion and megakaryocyte colony formation highlights its potential as a target in therapeutic interventions.